Abstract
Rapamycin (RPM) is frequently used as the drug coating in drug‑eluting stents (DESs) as it can inhibit the growth of smooth muscle cells. However, RPM also inhibits the proliferation and migration of vascular endothelial cells, and impairs reendothelialization in DES implantation. Therefore, the development of a strategy to protect vascular endothelial cells after DES implantation is of great importance. Long non‑coding RNAs (lncRNAs) metastasis‑associated lung adenocarcinoma transcript 1 (MALAT1) and smooth muscle and endothelial cell‑enriched migration/differentiation‑associated lncRNA (SENCR) are able to enhance the proliferation, migration and angiogenesis of endothelial cells, which suggests that they may have potential as antagonists of the adverse effects of RPM in DES. However, the relationship between RPM and lncRNAs in endothelial cells during the intervention is not fully understood at present. The current study investigated the role and potential mechanism of the lncRNA SENCR on the activity of human umbilical vein endothelial cells (HUVECs) after RPM treatment. The proliferation, migration, angiogenic capacity and cell cycle progression of lncRNA SENCR‑overexpressing HUVECs following RPM treatment was examined. The...Continue Reading
References
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Jan 6, 2007·Journal of Cardiovascular Pharmacology·Christian M MatterThomas F Lüscher
Mar 20, 2010·Journal of Interventional Cardiology·Eric ChongHuay Cheem Tan
Mar 1, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Robert D BellJoseph M Miano
Mar 8, 2014·Circulation Research·Katharina M MichalikStefanie Dimmeler
May 16, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Thomas Thum, Regalla Kumarswamy
Jun 6, 2015·Oncotarget·Chong XuLong Chen
Jul 15, 2015·Journal of Cardiovascular Pharmacology·Ning GuoYong Zhang
Sep 10, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhi-Qing ZouYe-Shan Han
Feb 24, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mounia BoulberdaaAndrew H Baker
Jul 23, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Jinjing ZhaoXiaochun Long
Aug 5, 2016·International Journal of Biological Sciences·Ping LiuP Andy Li
Nov 23, 2016·Scientific Reports·D de Gonzalo-CalvoT Thum
Jun 8, 2017·Experimental and Therapeutic Medicine·Liqin WuYuna Guo
Jun 9, 2017·Neoplasma·C WangJ L Shi
Jun 16, 2017·Molecular Cancer·Jayu JenYi-Ching Wang
Jun 18, 2017·Biochemical and Biophysical Research Communications·Rui ZhangHuaikun Ming
Jun 21, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Fangfang HuaJun Yang
Jun 22, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yuehua LiXiaoping Wu
Jun 27, 2017·Clinical Genitourinary Cancer·Chao LiXiong-Bing Zu
Jun 28, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianfa LiWeiren Huang
Jun 28, 2017·Molecular Cancer·Evan P BooySean A McKenna
Jun 28, 2017·Biochemical and Biophysical Research Communications·Jian-Hua XuPing Chen
Jun 28, 2017·EMBO Reports·Magdalena PruszkoGiulia Fontemaggi
Oct 6, 2017·Oncotarget·Jian-Yong SunXiao-Fei Li